USE OF WEAK OPIOIDS AND MIXED OPIOID AGONISTS/ANTAGONISTS FOR TREATING URINARY INCONTINENCE.

• 1. 用于治疗疼痛的防滥用的透皮递送装置和包含类阿片激动剂和不透皮递送的类阿片拮抗剂的N-氧化物衍生物的组合物 [P] . 中国专利： CN108601747A . 2018-09-28
• 2. 使用类阿片激动剂和/或类阿片拮抗剂的经皮药物输送系统、装置和方法 [P] . 中国专利： CN101321554A . 2008-12-10
• 3. USE OF WEAK OPIOIDS AND MIXED OPIOID AGONISTS/ANTAGONISTS FOR TREATING URINARY INCONTINENCE [P] . PL204246B1 . 2009-12-31

  机译： 使用弱阿片类药物和阿片类混合类激动剂/拮抗剂来治疗尿不便

• 4. Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence [P] . AU2002220736B2 . 2006-04-06

  机译： 弱阿片类药物和混合阿片类激动剂/拮抗剂治疗尿失禁的用途

• 5. USE OF WEAK OPIOIDS AND MIXED OPIOID AGONISTS/ANTAGONISTS FOR PREPARING OF PHARMACEUTICAL COMPOSITION FOR TREATING URINARY INCONTINENCE [P] . HU0303285A3 . 2005-05-30

  机译： 弱阿片类药物和阿片类混合类激动剂/拮抗剂的使用，用于制备药物成分来治疗尿不便

• 1. Kappa opioid receptor antagonist and N-methyl-D- aspartate receptor antagonist affect dynorphin- induced spinal cord electrophysiologic impairment [J] . Yu Chen, Liangbi Xiang, Jun Liu, 中国神经再生研究（英文版） . 2012,第007期
• 2. Functional expression of opioid receptor—like receptor and its endogenous specific agonist nociceptin／orphanin FQ during mouse embryogenesis [J] . WUYALAN, GUOHUANGFAN, 等 细胞研究：英文版 . 1997,第002期
• 3. Identification of opioid receptor ligand interactions using structurally related delta-opioid receptor agonists and antagonists and molecular modeling. [C] . Sharon D.Bryant, Yunden Jinsmaa, Lawrence H.Lazarus International Peptide Symposium;European Peptide Symposium . 2005
• 4. SAR studies on a weak delta opioid dipeptide antagonist (Tyr-Tic) and a potent mu opioid peptidomimetic agonist. [D] . Ma, Wenli. 2000
• 5. Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy Mu Opioid Receptor (MOR) Agonist/Delta Opioid Receptor (DOR) Antagonist Ligands [O] . Henry I. Mosberg, Larisa Yeomans, Aubrie A. Harland, -1
• 6. Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands [O] . Henry I. Mosberg, Larisa Yeomans, Aubrie A. Harland, 2013

• 1. Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon [J] . Bao-HuaLiu PingMo Sheng-BenZhang . 世界胃肠病学杂志：英文版 . 2004,第11期
• 2. DN-9: a multifunctional agonist of opioid and neuropeptide FF receptors that produces nontoleranceforming analgesia via peripheral opioid receptors in inflammatory and neuropathic pain models [J] . XU Biao ,ZHANG Meng-na ,SHI Xue-rui . 中国药理学与毒理学杂志 . 2018,第9期
• 3. REVERSIBLE BINGING OF NEW SYNTHESIZED OPIOID RECEPTOR LIGANDS TO CLONED OPIOID RECEPTORS STABLY EXPRESSED IN CHO CELL AND IDENTIFICAITON OF STIMULATING OPIOID RECEPTOR SUBTYPE [J] . Ping HU~1 Cai-Ying YE~1 Hui-Fen YANG~1 Zhui-Bai QIU~2 De-Chang ZHANG~1 ~1Department of Pharmacology Institute of Basic Medical Science Chinese Academy of Medical Sciences School of Basic Medicine Peking Union Medical College Belting 100005 ,~2College of Pharmacy Shanghai Medical University Shanghai 200000 . 神经解剖学杂志 . 2001,第B07期
• 4. 单纯强阿片类药物治疗控制癌痛与腹腔内生场热疗联合强阿片类药物治疗控制癌痛的效果比较 [C] . DING Zhao-heng ,丁昭珩 ,YAO Xiao-xiang . 第十三届全国癌症康复与姑息医学大会 . 2017
• 5. 华蟾素联合阿片类药物治疗阿片耐受患者癌痛的临床观察 [A] . 保卫东 . 2019